|
Market Closed -
Nasdaq Stockholm
09:30:00 11/09/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 8.990 SEK | +0.11% |
|
+1.93% | -33.41% |
| 13/08 | Vivesto narrowed its loss in the second quarter, CEO says: we are staying on plan | FW |
| 13/08 | Vivesto AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
| Market Cap | 9.95Cr 1.03Cr 88.51L 83.8L 75.96L 1.43Cr 98Cr 1.43Cr 3.83Cr 50Cr 3.86Cr 3.77Cr 157.76Cr | P/E 2026 * |
-2.99x | P/E 2027 * | -2.48x |
|---|---|---|---|---|---|
| Enterprise Value | 9.15Cr 94.47L 81.39L 77.07L 69.85L 1.31Cr 90Cr 1.32Cr 3.52Cr 46Cr 3.55Cr 3.47Cr 145.08Cr | EV / Sales 2026 * |
-
| EV / Sales 2027 * | - |
| Free-Float |
52.67% | Yield 2026 * |
-
| Yield 2027 * | - |
Nasdaq StockholmSEK
| Markets | Quality | ||
|---|---|---|---|
Nasdaq Stockholm
| VIVE | Delayed | |
Deutsche Boerse AG
| OMA | Delayed | |
|
CBOE
| 0N4A | Real-time | |
|
CBOE
| OASMs | Real-time | |
|
Börse Stuttgart
| OMA | Delayed |
Last Transcript : Vivesto AB
| 1 day | +0.11% | ||
| 1 week | +1.93% | ||
| Current month | +1.70% | ||
| 1 month | +3.69% | ||
| 3 months | +3.81% | ||
| 6 months | +11.96% | ||
| Current year | -33.41% |
| 1 week | 8.79 |  | 9.04 |
| 1 month | 8.5 | | 9.05 |
| Current year | 7 | | 19.5 |
| 1 year | 7 | | 27.3 |
| 3 years | 7 | | 90.6 |
| 5 years | 7 | | 302.9 |
| 10 years | 7 | | 1,670 |
| Manager | Title | Age | Since |
|---|---|---|---|
Erik Kinnman
CEO | Chief Executive Officer | 68 | 23/01/2023 |
Björn Svanström
DFI | Director of Finance/CFO | 55 | 01/07/2026 |
| Chief Tech/Sci/R&D Officer | 39 | 01/01/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 46 | 25/05/2022 | |
Hege Hellstrom
BRD | Director/Board Member | 61 | 26/09/2019 |
Pål Ryfors
BRD | Director/Board Member | 43 | 25/05/2022 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 25/03/22 | Buy | Chief Executive Officer | 12,200 | 0.0027% | ||
| 24/03/22 | Others | Chairman | 1,20,000 | 0.0268% | ||
| 20/12/21 | Free | Chief Executive Officer | 22,50,000 | 0.5018% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.11% | +1.93% | -59.60% | -57.09% | 1.03Cr | |
| -0.65% | -2.93% | +47.70% | +86.17% | 99TCr | |
| -0.29% | -3.51% | +49.15% | +62.35% | 64TCr | |
| +0.83% | +0.26% | +17.76% | +72.25% | 45TCr | |
| -0.38% | -3.59% | +30.13% | +35.17% | 34TCr | |
| -0.09% | -13.54% | +13.34% | +24.95% | 26TCr | |
| -0.43% | -2.48% | -0.73% | +9.58% | 25TCr | |
| -1.34% | -13.70% | +36.53% | +44.96% | 20TCr | |
| -3.44% | -7.51% | -20.63% | -59.44% | 19TCr | |
| -0.75% | -4.82% | +25.46% | +87.14% | 18TCr | |
| Average | -0.64% | -4.99% | +13.91% | +30.60% | 35.05TCr | |
| Weighted average by Cap. | -0.51% | -4.42% | +30.96% | +54.95% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | - |
| Net income | -3.1Cr -31.99L -27.57L -26.1L -23.66L -44.38L -31Cr -44.61L -1.19Cr -16Cr -1.2Cr -1.18Cr -49Cr | -4Cr -41.28L -35.57L -33.68L -30.53L -57.27L -39Cr -57.56L -1.54Cr -20Cr -1.55Cr -1.52Cr -63Cr |
| Net Debt | -80L -8L -7L -7L -6L -11.45L -7.89Cr -11.51L -30.76L -4.01Cr -31.01L -30.33L -13Cr | -1.7Cr -17.54L -15.12L -14.31L -12.97L -24.34L -17Cr -24.46L -65.37L -8.53Cr -65.89L -64.45L -27Cr |
Employees
4
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 11/26/11 | SEK 8.990 | +0.11% | 918 |
| 10/26/10 | SEK 8.980 | -0.22% | 6,457 |
| 09/26/09 | SEK 9.000 | +2.27% | 6,779 |
| 08/26/08 | SEK 8.800 | -2.00% | 3,017 |
| 07/26/07 | SEK 8.980 | +1.81% | 2,950 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- VIVE Stock
Select your edition
All financial news and data tailored to specific country editions
